Good MorningThe tug of war between bulls and bears continued on Thursday with the bears winning out. The rising tide of fear that is driven by inflation and the FOMC’s rapidly accelerating timeline for interest rate hikes has the market on edge. While rising interest rates are a sign of economic expansion and it is very, very early in the rate hiking cycle, there are those who think the FOMC is behind the curve and will raise rates and a much faster pace than seen before.
The latest look at the CME FedWatch Tool shows the market is pricing in at least a 50% chance for 4 interest rate hikes by the end of the year. Based on this week’s CPI and PPI data, we think the first hike will be at least 50 basis points or worth half of the 4 hike outlook. As for the S&P 500, it looks like the market could head lower but earnings season begins today and that could change the entire mood on Wall Street.
Featured: Your Bank Account Is No Longer Safe (Ad) 
|
Politics | | | China’s politically volatile global trade surplus surged to $676.4 billion in 2021, likely the highest ever for any country, as exports jumped 29.9% over a year earlier despite semiconductor shortages that disrupted manufacturing.
The country’s monthly trade surplus in December swelle... Read the Full Story |
|
From Our PartnersAs you may have seen over the last few weeks, I've been giving out special daily setups on my favorite ticker.
We’ve been taking these setups @ 10AM and so far, we've posted 28 different payouts …
Each of which were delivered at exactly 4PM as the market closed.
You see, these setups require zero oversight and have shown the power to deliver in the most chaotic market conditions.
And after a few weeks of fine-tuning … I knew it was time to let you in on The 4 PM Payout Plan.
That's why Jack Carter and I pulled back the curtain to reveal how we've been able to nail in a 96% win rate in the same window the market lost 11 trillion dollars in value. | | | We also revealed how you can find and execute these setups on your own without any help at all. |
|
Markets | | | While all signs point towards a strong year for this sector, investors still need to be highly selective when putting money to work at this time. That’s why we’ve put together the following list of 3 interesting industrial stocks to buy now to help you narrow your focus towards the best of the best. Read the Full Story |
|
Tech | | | Technology companies led stocks lower on Wall Street in afternoon trading Thursday as investors gauged the latest data on inflation and company earnings.
The S&P 500 fell 1.1% as of 3:24 p.m. Eastern. The benchmark index is coming off two days of gains following daily losses since... Read the Full Story |
|
|
Politics | | | Europe’s natural gas crisis isn't letting up. Reserves are low. Prices are high. Utility customers are facing expensive bills. Major Russian supplier Gazprom isn't selling gas like it used to.
It all raises the question: How exactly is Europe, which imports most of its energy, going t... Read the Full Story |
|
Markets | | | Delta Air Lines lost $408 million in the final quarter of 2021, dragged down by a COVID-19 surge that rocked the airline in December, and the carrier predicted Thursday that it will suffer one more quarterly loss before travel perks up in spring and summer.
CEO Ed Bastian said 8,000 e... Read the Full Story |
|
|
Politics | | | Mexican President Andrés Manuel López Obrador said Thursday he hopes Mexican investors buy the local subsidiary of Citigroup.
In a post on social media, the president said that “we would like this bank to be Mexicanized,” contending that foreign bankers often take profits abroad rath... Read the Full Story |
|
Markets | | |
As 2022 goes into full swing, it stands to reason that as the pandemic doesn't impose quite the burden that it once did, consumer discretionary spending will tick upward. After all, nonessential products and services will come into vogue again, right? (Aren't we beyond the need for just toilet pap... Read the Full Story |
|
Markets | | | The analysts have been getting incrementally more bullish on Caterpillar (NYSE: CAT) over the past 12 months and we see this activity driving share prices back to the all-time high set in 2021, at least. Activity since the start of 2022 includes three price target increases that pushed the Marketbeat.com consensus estimate to a new 1-year high. Read the Full Story |
|
Markets | | | Infosys (NYSE: INFY) has been working hard on a digital transformation that just so happened to set the company up perfectly for the pandemic and the post-pandemic world. A consulting and outsourcing firm, Infosys’ transformation is centered on digital and includes “re-skilling” its talent pool, investing in new talent, investing in technology, and making itself a business-services company of the future, not the past Read the Full Story |
|
Stocks | | |
Space tourism pioneer Virgin Galactic Holdings, Inc. (NYSE: SPCE) stock has collapsed below pandemic lows after its initial space flight carrying its chairman Richard Branson. What initially seemed like a step forward moving towards significant revenue generation was pushed back as the Company del... Read the Full Story |
|
Friday's Early Bird Stock Of The Day IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina. | | View Today's Stock Pick |
|
